10 Best AI Driven Biotech Stocks to Invest In
In this article, we will take a look at some of the best AI driven biotech stocks that are currently offering attractive upside potential.
Ideaya Biosciences Inc. (IDYA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 891,608 | $33,230,230 | 0.01% | |
| 2. | Fisher Asset Management Ken Fisher | 851,306 | $31,728,173 | -4% | 0.01% |
| 3. | Walleye Capital Will England | 386,183 | $14,393,040 | 0.05% | |
| 4. | Rhenman & Partners Asset Management Henrik Rhenman | 343,800 | $12,813,426 | +35% | 1.21% |
| 5. | BIT Capital GmbH Jan Beckers | 311,333 | $11,603,381 | 0.34% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $32.96 | 50,000 | $1,647,890.00 | 54,281 | 2026-03-02 | Filing | |
| $13.32 | 81 | $1,078.63 | 237,475 | 2020-06-30 | Filing | |
| $13.32 | 929 | $12,370.94 | 1,204,981 | 2020-06-30 | Filing | |
| $13.32 | 1,521 | $20,254.24 | 1,667,420 | 2020-06-30 | Filing | |
| $13.93 | 1,354 | $18,867.58 | 237,394 | 2020-06-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $40.01 | 9,550 | $382,130.84 | 26,466 | 2026-07-07 | Filing | |
| $36.78 | 851 | $31,296.63 | 0 | 2024-05-29 | Filing | |
| $36.23 | 27,649 | $1,001,587.79 | 851 | 2024-05-29 | Filing | |
| $42.37 | 4,349 | $184,249.73 | 677,887 | 2024-05-16 | Filing | |
| $41.73 | 30,084 | $1,255,504.60 | 682,236 | 2024-05-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,109,431 | $525,858,476 | 0.02% | |
| 2. | 8,893,260 | $331,451,800 | 0% | |
| 3. | 5,344,701 | $199,197,006 | 0.03% | |
| 4. | 4,548,911 | $169,537,913 | 0.01% | |
| 5. | 4,132,646 | $154,023,716 | 0% |
News See All
Is IDEAYA Biosciences, Inc. (IDYA) A Good Stock To Buy Now?
Is IDYA a good stock to buy? We came across a bullish thesis on IDEAYA Biosciences, Inc. on Valueinvestorsclub.com by pestopenguin. In this article, we will summarize the bulls’ thesis on IDYA.
IDEAYA Biosciences, Inc. (IDYA) PT Increased as Wedbush Highlights Positive OptimUM-02 Trial Readout
TheFly reported on April 14 that Wedbush Securities increased its price target on IDYA from $52 to $58 while maintaining an Outperform rating.
Top 10 AI-Powered Biotech Stocks to Buy Right Now
Franklin Equity reported on February 16 that, following a protracted period of uncertainty in the previous year, the biotechnology sector has entered 2026 on a firmer and more stable foundation.
IDEAYA Biosciences, Inc. (IDYA) Enrolls First Patient in Phase 1 Trial of IDE034 Bispecific ADC
On February 25, 2026, IDEAYA Biosciences, Inc.
10 Fastest Growing NASDAQ Stocks to Buy
High growth stocks have once again taken center stage, and major asset managers argue that earnings momentum remains the decisive factor. In its 2026 Year-Ahead Investment Outlook, J.P.
Citizens JMP Remains Bullish on IDEAYA Biosciences (IDYA)
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is one of the best healthcare stocks with the highest upside. Citizens JMP analyst Silvan Tuerkcan released a rating update for IDEAYA Biosciences, Inc.
9 Best Healthcare Stocks with the Highest Upside
Talking about how people are feeling the impact of the shutdown, Dr.
J.P. Morgan Remains Bullish on IDEAYA Biosciences (IDYA)
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is one of the best biotech stocks with high potential. On September 23, J.P. Morgan analyst Anupam Rama maintained a bullish stance on IDEAYA Biosciences, Inc.
14 Biotech Stocks with High Potential
Healthcare was the second worst performer this year, with pharma and biotech companies under pressure.
Hedge Fund Resource Center